Holdings
Elmind Capital, LP
As of Sep 30, 2026, Elmind Capital, LP reported 28 positions worth US$369M. Largest: Celldex Therapeutics, Inc., Legend Biotech Corp. and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Celldex Therapeutics, Inc. | 1.11M | US$36M | +120K | Sep 30, 2026 |
| Legend Biotech Corp. | 1.57M | US$31.2M | new | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.6M | US$30.2M | −250K | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 867K | US$27.8M | −304K | Sep 30, 2026 |
| Relay Therapeutics, Inc. | 1.47M | US$26.4M | no change | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 895K | US$26M | +783K | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 1.22M | US$25.2M | +240K | Sep 30, 2026 |
| Vaxcyte, Inc. | 372K | US$21.2M | −80,000 | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 323K | US$19M | +30,000 | Sep 30, 2026 |
| Cullinan Therapeutics, Inc. | 963K | US$14.8M | +273K | Sep 30, 2026 |